ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 693248 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 693248; 2) Community: the network communities that were significantly associated with the response to NSC 693248; 3) Molecule: the relationships between components within communities and NSC 693248; 4) MDR: the compounds that were significantly associated with the NSC 693248.

NSC Compound Enrichment Correlation
NSC 628918 3-(2-N,N-diethylaminoethylamino)-7-nitro-1,2,4- benzotriazine 1,4-dioxide . Hydrochloride 0.0236268253072453 0.41692925
NSC 639517 Cyclopentanone, 2-[(4-chlorophenyl)methylene]-5-[(4- morpholinyl)methyl]-, hydrochloride 0.0236268253072453 0.37306295
NSC 668257 2,4(1H,3H)-Pyrimidinedione, 1-[[2-(4-chlorophenyl)- tetrahydro-4-methylene-5-oxo-2-furanyl]methyl]-5-methyl- 0.0236268253072453 0.31429133
NSC 685470 Null 0.0236268253072453 0.15935957
NSC 106557 5.alpha.,25D-Spirostan-3.beta.-ol glycoside 0.0237269271456697 -0.061569981
NSC 132230 Null 0.0237269271456697 0.2380366
NSC 158088 Null 0.0237269271456697 0.20067214
NSC 266046 Oxaliplatin 0.0237269271456697 0.25443979
NSC 281279 Platinum, aqua(1,2-cyclohexanediamine-N,N')(tetraoxoselenato(2-)-O)-, (SP-4-3)- 0.0237269271456697 0.35207125
NSC 329515 Kijanimicin sodium salt 0.0237269271456697 0.015654067
Total:96  Current:59    [First] [Prev] [Next] [Last]